Hypercholesterolemia News and Research

RSS
Hypercholesterolemia is a condition characterized by very high levels of cholesterol in the blood. Cholesterol is a waxy, fat-like substance that is produced in the body and obtained from foods that come from animals (particularly egg yolks, meat, poultry, fish, and dairy products). The body needs this substance to build cell membranes, make certain hormones, and produce compounds that aid in fat digestion. Too much cholesterol, however, increases a person's risk of developing heart disease.

People with hypercholesterolemia have a high risk of developing a form of heart disease called coronary artery disease. This condition occurs when excess cholesterol in the bloodstream is deposited in the walls of blood vessels, particularly in the arteries that supply blood to the heart (coronary arteries). The abnormal buildup of cholesterol forms clumps (plaque) that narrow and harden artery walls. As the clumps get bigger, they can clog the arteries and restrict the flow of blood to the heart. The buildup of plaque in coronary arteries causes a form of chest pain called angina and greatly increases a person's risk of having a heart attack.

Inherited forms of hypercholesterolemia can also cause health problems related to the buildup of excess cholesterol in other tissues. If cholesterol accumulates in tendons, it causes characteristic growths called tendon xanthomas. These growths most often affect the Achilles tendons and tendons in the hands and fingers. Yellowish cholesterol deposits under the skin of the eyelids are known as xanthelasmata. Cholesterol can also accumulate at the edges of the clear, front surface of the eye (the cornea), leading to a gray-colored ring called an arcus cornealis.
Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

AMT inks agreement with Progenika Biopharma for development of LPLchip

AMT inks agreement with Progenika Biopharma for development of LPLchip

United States Patent and Trademark Office allows a patent application within ‘Esau’ patent family

United States Patent and Trademark Office allows a patent application within ‘Esau’ patent family

KOKEN receives license to manufacture and provide RNAi research products under Kreutzer-Limmer patent family

KOKEN receives license to manufacture and provide RNAi research products under Kreutzer-Limmer patent family

LIVALO statin effective than simvastatin in reducing lipid levels

LIVALO statin effective than simvastatin in reducing lipid levels

Progenika to provide blood group genotyping reference laboratory services to ARUP

Progenika to provide blood group genotyping reference laboratory services to ARUP

AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH

AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH

RXi Pharmaceuticals presents new preclinical data from its advanced RNAi therapeutic platform

RXi Pharmaceuticals presents new preclinical data from its advanced RNAi therapeutic platform

FDA approves Daiichi Sankyo's sNDA for Welchol

FDA approves Daiichi Sankyo's sNDA for Welchol

Merz publishes Phase III study results assessing the impact of NT 201 on muscle tone

Merz publishes Phase III study results assessing the impact of NT 201 on muscle tone

Actavis' clients launch generic Atorvastatin in Spain

Actavis' clients launch generic Atorvastatin in Spain

JPO to grant patent from the Tuschl III patent series

JPO to grant patent from the Tuschl III patent series

Alnylam and Medtronic announce pre-clinical research findings from their Huntington’s disease program

Alnylam and Medtronic announce pre-clinical research findings from their Huntington’s disease program

USPTO allows Isis an additional patent for single-stranded RNAi technology

USPTO allows Isis an additional patent for single-stranded RNAi technology

Merck update on the status of telcagepant clinical development programs

Merck update on the status of telcagepant clinical development programs

EPO issues grant for a patent in Kreutzer-Limmer III patent series

EPO issues grant for a patent in Kreutzer-Limmer III patent series

High-density lipoprotein cholesterol concentrations increased in patients treated with LIVALO

High-density lipoprotein cholesterol concentrations increased in patients treated with LIVALO

Research study concludes the difference in mortality between men and women depending on the type of ACS

Research study concludes the difference in mortality between men and women depending on the type of ACS

Alnylam and Tekmira to collaborate on RNAi therapeutics

Alnylam and Tekmira to collaborate on RNAi therapeutics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.